000136970 001__ 136970
000136970 005__ 20240229105109.0
000136970 0247_ $$2doi$$a10.1038/s41398-018-0221-8
000136970 0247_ $$2pmid$$apmid:30143603
000136970 0247_ $$2pmc$$apmc:PMC6109140
000136970 0247_ $$2altmetric$$aaltmetric:47151582
000136970 037__ $$aDKFZ-2018-01399
000136970 041__ $$aeng
000136970 082__ $$a610
000136970 1001_ $$0P:(DE-HGF)0$$aStocker, Hannah$$b0$$eFirst author
000136970 245__ $$aThe genetic risk of Alzheimers disease beyond APOE ε4: systematic review of Alzheimers genetic risk scores.
000136970 260__ $$aLondon$$bNature Publishing Group$$c2018
000136970 3367_ $$2DRIVER$$aarticle
000136970 3367_ $$2DataCite$$aOutput Types/Journal article
000136970 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1536655084_1930$$xReview Article
000136970 3367_ $$2BibTeX$$aARTICLE
000136970 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000136970 3367_ $$00$$2EndNote$$aJournal Article
000136970 520__ $$aThe ε4 allele of Apolipoprotein E (APOE) is the strongest known genetic risk factor of Alzheimer's disease (AD) but does not account for the entirety of genetic risk. Genetic risk scores (GRSs) incorporating additional genetic variants have been developed to determine the genetic risk for AD, yet there is no systematic review assessing the contribution of GRSs for AD beyond the effect of APOE ε4. The purpose of this systematic PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses)-based review was to summarize original research studies that have developed and validated a GRS for AD utilizing associated single nucleotide polymorphisms (SNPs). The PubMed and Web of Science databases were searched on April 6, 2018 and screening was completed on 2018 citations by two independent reviewers. Eighteen studies published between 2010 and 2018 were included in the review. All GRSs expressed significant associations or discrimination capability of AD when compared to clinically normal controls; however, GRS prediction of MCI to AD conversion was mixed. APOE ε4 status was more predictive of AD than the GRSs, although the GRSs did add to AD prediction accuracy beyond APOE ε4. GRSs might contribute to identifying genetic risk of AD beyond APOE. However, additional studies are warranted to assess the performance of GRSs in independent longitudinal cohorts.
000136970 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000136970 588__ $$aDataset connected to CrossRef, PubMed,
000136970 7001_ $$0P:(DE-HGF)0$$aMöllers, Tobias$$b1
000136970 7001_ $$0P:(DE-He78)d9d72431035d8535d1b65ce9a01c2f60$$aPerna, Laura$$b2$$udkfz
000136970 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b3$$eLast author$$udkfz
000136970 773__ $$0PERI:(DE-600)2609311-X$$a10.1038/s41398-018-0221-8$$gVol. 8, no. 1, p. 166$$n1$$p166$$tTranslational Psychiatry$$v8$$x2158-3188$$y2018
000136970 909CO $$ooai:inrepo02.dkfz.de:136970$$pVDB
000136970 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000136970 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000136970 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d9d72431035d8535d1b65ce9a01c2f60$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000136970 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000136970 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000136970 9141_ $$y2018
000136970 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bTRANSL PSYCHIAT : 2015
000136970 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000136970 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000136970 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000136970 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000136970 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000136970 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000136970 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000136970 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000136970 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000136970 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000136970 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bTRANSL PSYCHIAT : 2015
000136970 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000136970 980__ $$ajournal
000136970 980__ $$aVDB
000136970 980__ $$aI:(DE-He78)C070-20160331
000136970 980__ $$aUNRESTRICTED